Macrocephaly Macrosomia and Facial Dysmorphism Syndrome

Macrocephaly, macrosomia, and facial dysmorphism syndrome (often shortened to MMFD) is a very rare genetic overgrowth condition. Children with this syndrome usually have a very large head (macrocephaly), a big body size or high weight for their age (macrosomia), and special facial features that look different from most children (facial dysmorphism). They often grow faster than other children, may be taller, and can have learning problems or intellectual disability.

In most known patients, the problem comes from a change (mutation) or small missing piece (microdeletion) on chromosome 17 in a region that includes a gene called RNF135. This change affects how the body controls growth and brain development and is passed in an autosomal dominant way, which means one changed copy of the gene is enough to cause the condition.

Macrocephaly, macrosomia, and facial dysmorphism syndrome (often called MMFD) is a rare genetic overgrowth condition. Children are usually born with a large head (macrocephaly), high birth weight or length (macrosomia), and a characteristic facial appearance such as broad forehead, wide-set eyes, or coarse features. Many children also have learning difficulties, developmental delay, and sometimes features overlapping with neurofibromatosis type 1 due to changes in genes on chromosome 17q11.2, especially RNF135 and sometimes NF1. [1]

Macrocephaly means the head circumference is larger than expected for age and sex (usually above +2 or +2.5 standard deviations). Macrocephaly can be caused by extra brain tissue, extra fluid (hydrocephalus), thick skull bones, or a combination of these. In MMFD and related overgrowth syndromes, the large head is usually due to true brain overgrowth and abnormal brain development rather than simple extra fluid. [2]

Macrosomia describes a baby whose birth weight is higher than 4,000 g or above the 90th percentile for gestational age. Large-for-gestational-age babies can have more delivery complications, breathing problems, low blood sugar, and later obesity or metabolic issues, so careful monitoring around birth is important. In MMFD, macrosomia is part of a broader lifelong overgrowth pattern rather than just a pregnancy-related problem. [3]

Facial dysmorphism means that facial features have an unusual shape or proportion. In MMFD and related overgrowth conditions, children may have a tall forehead, full lips, broad nasal bridge, widely spaced eyes, and sometimes coarse facial features. These facial findings, combined with macrocephaly, tall stature, and developmental delay, help geneticists recognize an overgrowth syndrome and decide which genetic tests to order. [4]

MMFD is usually caused by microdeletions or mutations in the RNF135 gene within the 17q11.2 region. This region also includes the NF1 gene, so some patients show both MMFD-type overgrowth and typical NF1 features such as café-au-lait spots, skin neurofibromas, and plexiform neurofibromas. This overlap is why MMFD is often listed together with “chromosome 17q11.2 deletion syndrome” and “NF1 microdeletion syndrome” in rare disease catalogues. [5]

Other names

This syndrome is known in the medical literature by several other names. These names all point to the same or very closely related conditions:

• Chromosome 17q11.2 deletion syndrome, 1.4-Mb

• NF1 microdeletion syndrome

• Overgrowth-macrocephaly-facial dysmorphism syndrome

• RNF135-related overgrowth syndrome

• Van Asperen syndrome

• Monosomy 17q11

• Neurofibromatosis type 1 microdeletion syndrome (in many patients with the same 17q11.2 region missing)

Doctors may use different names depending on which part of the chromosome is affected, which gene is changed, and which symptoms are most obvious.

Types

There is no strict official “type 1, type 2” system, but doctors often group patients into a few practical types based on the exact genetic change and the clinical picture:

• Type 1 – RNF135 single-gene mutation type
  Children have a mutation in the RNF135 gene, usually without a large piece of chromosome missing. They show overgrowth, macrocephaly, learning problems, and facial differences.

• Type 2 – 17q11.2 microdeletion (NF1 microdeletion) type
  A small piece of chromosome 17q11.2 is missing. This includes RNF135 and often the NF1 gene. Children have overgrowth plus signs of neurofibromatosis type 1 (such as café-au-lait spots and neurofibromas) and more severe learning problems.

• Type 3 – Overgrowth-dominant type
  Overgrowth (very tall, big head, big body) and facial dysmorphism are strong, while NF1-related skin or tumor signs are mild or appear later.

• Type 4 – NF1-dominant type
  NF1-related skin spots, neurofibromas, and other NF1 complications are very clear, with macrocephaly and macrosomia also present, but facial changes may be less striking.

Causes

First, it is important to say that the main true cause is a genetic change, not anything the parents did or did not do. Many of the points below describe different ways this genetic change can happen or how it can affect the body.

1. RNF135 gene mutation
A harmful change in the RNF135 gene is the best-known direct cause. This gene helps control other proteins and signals that guide growth and brain development. When it does not work properly, the child’s body and head can grow too much and brain wiring can be altered.

2. 17q11.2 microdeletion including RNF135
Some children do not have only a small mutation but are missing a piece of chromosome 17q11.2. This missing part includes RNF135 and often NF1. Losing these genes at once disturbs several growth-control pathways and leads to overgrowth, macrocephaly, and facial dysmorphism.

3. Involvement of the NF1 region
The NF1 gene region, which lies close to RNF135, is often deleted in this syndrome. NF1 normally acts like a “brake” on cell growth. When NF1 is missing, cells can grow and divide more, contributing to tall stature, macrocephaly, and a higher risk of some tumors.

4. Autosomal dominant inheritance
The condition can be passed from a parent who has the mutation or deletion to their child. Only one changed copy of the gene is needed. A parent with the syndrome (even if mildly affected) has a 50% chance in each pregnancy to pass on the changed gene.

5. De novo (new) mutations
In many cases, neither parent has the syndrome. The mutation or deletion occurs “out of the blue” in the egg, sperm, or very early embryo. This is called a de novo change. It is not caused by anything the parents did; it just happens by chance when DNA copies itself.

6. Gene dosage effect of RNF135
When RNF135 is missing or changed, the amount of working protein in the cell is reduced. This “dosage effect” can disturb networks that control brain size and body growth, leading to macrocephaly and macrosomia.

7. Combined loss of several genes in 17q11.2
The 17q11.2 region contains several genes. When a microdeletion removes many of them at once, the child may have a broader and more severe picture: overgrowth, learning problems, and multiple organ involvement. The combined gene loss explains why some children are more affected than others.

8. Disruption of brain growth pathways
Genes in this region are involved in brain cell growth and connections. When they are damaged, brain volume can increase (megalencephaly), leading to macrocephaly and sometimes seizures or neurodevelopmental problems.

9. Disruption of body growth pathways
Growth-control signals, such as those using RAS-MAPK and other pathways, can be disturbed by 17q11.2 deletion and RNF135 changes. This can cause whole-body overgrowth, tall stature, and increased weight (macrosomia).

10. Epigenetic and regulatory changes around RNF135
Sometimes the DNA sequence is not missing, but the way it is “read” is changed. Chemical tags on DNA or nearby control regions can alter how much RNF135 and nearby genes are expressed, possibly modifying the severity of the syndrome.

11. Unbalanced chromosomal rearrangements
In rare families, a parent may carry a balanced rearrangement involving chromosome 17q11.2. When passed on in an unbalanced form, the child can lose the 17q11.2 segment, causing MMFD features.

12. Parental germline mosaicism
Very rarely, one parent may have a mutation or deletion only in some egg or sperm cells (germline mosaicism) while appearing healthy. This can cause MMFD in more than one child in the family.

13. Interaction with other overgrowth genes
Other overgrowth syndromes (such as Sotos or Beckwith-Wiedemann) share overlapping growth pathways. If a child also carries variants in these pathways, the overgrowth and macrocephaly can be stronger.

14. Genetic background (modifier genes)
Every person has many genes that can slightly increase or decrease growth. These background genes may change how severe the head size, body size, and learning problems become in a child with MMFD.

15. Prenatal overgrowth tendency
The genetic changes are already present before birth, so many babies show fast growth in the womb and are large at birth. This prenatal overgrowth is part of the cause of macrosomia and macrocephaly in newborns.

16. Disturbed bone growth and bone age
Like other overgrowth syndromes, bone growth may be ahead of normal age (advanced bone age). This can contribute to tall stature, large hands and feet, and changes in skull shape.

17. Altered brain connectivity linked to autism traits
RNF135 changes have been linked in some patients to autism spectrum disorder. The same brain wiring changes that raise autism risk may also affect learning, speech, and behavior in MMFD.

18. Increased tumor risk in some NF1-related cases
When NF1 is also deleted, cell growth control is weaker, and some children have a higher risk of benign or malignant tumors. This altered growth control is another aspect of the underlying cause.

19. Possible influence of maternal conditions (co-factor)
Conditions like poorly controlled maternal diabetes can also cause fetal overgrowth and macrosomia. In a baby with MMFD, such factors may further increase birth size, but they do not cause the genetic syndrome itself.

20. Unknown or yet-undiscovered genetic factors
Because MMFD is very rare, not all genetic changes have been found. Some children with a very similar picture may have changes in nearby or related genes that have not yet been fully described.

Symptoms

1. Macrocephaly (very large head)
The child’s head size is much bigger than average for age and sex, usually above the 98th percentile. Doctors measure this with a tape measure around the skull. Macrocephaly may be due to a larger brain (megalencephaly) or thicker skull bones, and it is one of the main signs of this syndrome.

2. Macrosomia (large body size or weight)
Babies are often heavier and sometimes longer than expected at birth, and they may continue to be bigger than their peers. This is called macrosomia and is part of the overgrowth picture seen in this and other overgrowth syndromes.

3. Tall stature
As the child grows, their height can stay above the normal range for age, often above the 97th percentile. They may be noticeably taller than classmates, which can affect body image and daily life.

4. Facial dysmorphism (unusual facial features)
Children have a special facial appearance that may include a broad or high forehead, wide-set eyes, a prominent jaw, or other subtle features. These features help expert doctors recognize the pattern and think about MMFD or related overgrowth syndromes.

5. Learning difficulties
Many children have trouble with school learning. They may need more time to read, write, or do math and often benefit from special education and extra support. This can range from mild learning difficulty to more marked intellectual disability.

6. Intellectual disability
Some children have a lower overall IQ and difficulties with understanding complex ideas, planning, or problem-solving. Intellectual disability can vary from mild to moderate and affects school, work, and independence.

7. Developmental delay
Motor skills (like sitting, crawling, walking) and speech may appear later than usual. Parents may notice that the child reaches milestones more slowly and may need physiotherapy, occupational therapy, and speech therapy.

8. Autism spectrum features or social communication problems
Some children with RNF135 changes show autism spectrum traits, such as difficulties with eye contact, social interaction, flexible thinking, or repetitive behaviors. Early diagnosis can help the child get behavioral and communication support.

9. Hypotonia (low muscle tone)
Babies may feel “floppy” when held, and older children can seem weak or tire easily. Low muscle tone can affect sitting and walking and may contribute to delays in motor milestones.

10. Joint hyperlaxity and skeletal problems
Some children have very flexible joints (hyperlaxity), flat feet, or spinal problems such as scoliosis. These problems can cause pain or posture issues and sometimes need orthopedic follow-up.

11. Seizures (in some patients)
A few patients with macrocephaly and overgrowth syndromes may develop seizures. Seizures can look like staring spells, shaking, or loss of awareness and require evaluation and treatment by a neurologist.

12. Behavioral and emotional difficulties
Children may show hyperactivity, anxiety, mood swings, or attention problems. These may be linked to brain development differences and can affect school and social life.

13. Speech and language delay
Many children talk later than their peers or have trouble expressing themselves clearly. They may also have difficulty understanding complex language. Speech therapy is often helpful.

14. Possible skin and NF1-related signs
In children with 17q11.2 microdeletions that include NF1, there may be café-au-lait spots, freckling in the armpits or groin, or small benign nerve tumors (neurofibromas). These are classic NF1 features and help guide the diagnosis.

15. Other organ involvement (variable)
Some children may have heart, kidney, or other organ abnormalities, but this is not present in all cases. Because the deletion can affect many genes, the exact combination of features can vary widely from child to child.

Diagnostic tests

Doctors use a mix of clinical examination, manual bedside tests, laboratory and pathology tests, electrodiagnostic tests, and imaging tests to diagnose MMFD and rule out other conditions.

Physical examination tests

1. Growth measurements (head, weight, height)
The doctor measures head circumference, body weight, and height and plots them on standard growth charts. Macrocephaly is usually defined as head size above the 98th percentile, and macrosomia and tall stature are defined by weight and height far above average for age and sex.

2. Detailed facial examination
A clinical geneticist looks closely at the face, including forehead shape, eye spacing, nose, jaw, and mouth. A pattern of facial dysmorphism together with macrocephaly and overgrowth can suggest MMFD or related overgrowth syndromes and guide genetic testing.

3. Full body and skeletal examination
The doctor examines limb length, spine shape, joint flexibility, hands and feet, and any chest or abdominal differences. Overgrowth, scoliosis, joint hyperlaxity, or other skeletal changes can support the diagnosis and help rule out other overgrowth conditions.

4. Skin and neurologic examination
The skin is checked for café-au-lait spots, freckling, and neurofibromas, which suggest NF1 microdeletion. A neurologic exam looks at reflexes, muscle tone, coordination, and signs of seizures or other brain involvement.

Manual bedside and developmental tests

5. Developmental milestone assessment
Using structured questions and simple tasks, the clinician checks when the child first smiled, sat, walked, and spoke. Delays in multiple areas (motor, speech, social) raise concern for a neurodevelopmental syndrome such as MMFD and indicate the need for detailed evaluation.

6. Motor and tone assessment (physiotherapy tests)
Physiotherapists perform hands-on tests such as pull-to-sit, standing balance, and walking pattern evaluation. These manual tests show if there is low muscle tone, poor coordination, or joint instability that fits with an overgrowth and neurodevelopmental syndrome.

7. Vision screening and eye examination
The child’s ability to fix and follow, read eye charts (if old enough), and eye movements are checked. Some overgrowth and NF1-related conditions have eye changes, so this manual and instrument-based exam is useful for both diagnosis and monitoring.

8. Hearing screening
Simple bedside tests (such as response to sound) plus formal hearing tests (like otoacoustic emissions or audiometry) help detect hearing problems. Hearing loss can worsen learning and speech problems, so it must be identified early even if it is not a direct feature of MMFD in every case.

Laboratory and pathological tests

9. Basic blood tests (CBC, metabolic panel)
A complete blood count and basic metabolic tests help rule out other causes of developmental delay or large head, such as infections, anemia, or metabolic disorders. Normal results support the idea that the main problem is genetic rather than acquired.

10. Hormone and endocrine tests (if needed)
Tests for thyroid function, growth hormone, and insulin-like growth factor 1 (IGF-1) can be done if there is concern about other hormonal causes of overgrowth. These tests help separate MMFD from other endocrine overgrowth conditions.

11. Chromosomal microarray analysis (CMA)
CMA is a detailed DNA test that looks for missing or extra pieces of chromosomes. It is a key test for MMFD because it can detect the 17q11.2 microdeletion that includes RNF135 and NF1. This result often provides a clear genetic diagnosis.

12. Targeted NF1 microdeletion testing
If NF1 features are present, labs may perform specific tests aimed at the NF1 region to look for microdeletions. When a microdeletion is found that also includes RNF135, this confirms the link with MMFD and NF1 microdeletion syndrome.

13. RNF135 gene sequencing
If no microdeletion is seen, sequencing of the RNF135 gene can be done to look for point mutations or small insertions/deletions. Finding a pathogenic RNF135 mutation confirms the diagnosis of RNF135-related overgrowth with macrocephaly and facial dysmorphism.

14. Whole-exome or whole-genome sequencing
In complex cases, broad sequencing of many genes (exome or genome) can be used. This can detect rare or novel variants in RNF135 or nearby genes and is helpful when standard tests are negative but clinical suspicion is high.

Electrodiagnostic tests

15. Electroencephalogram (EEG)
If the child has suspected seizures, an EEG records brain electrical activity through small scalp electrodes. Patterns on EEG can confirm seizures, help choose treatment, and show how the brain is functioning in an overgrowth and macrocephaly syndrome.

16. Nerve conduction studies and electromyography (EMG) – selected cases
When there are signs of muscle weakness or peripheral nerve problems, nerve conduction and EMG tests may be done. They measure how fast nerves carry signals and how muscles respond. While not routine in all MMFD patients, they can help rule out other neuromuscular conditions.

Imaging tests

17. Brain MRI
Magnetic resonance imaging (MRI) gives detailed pictures of the brain. In macrocephaly and overgrowth syndromes, MRI can show an enlarged brain, enlarged ventricles, or other subtle changes, and exclude hydrocephalus or major malformations. Findings help confirm that macrocephaly is part of a genetic growth syndrome.

18. Cranial ultrasound (in babies)
For young infants with open fontanelles (“soft spots”), cranial ultrasound is a simple, safe imaging test. It can quickly rule out hydrocephalus or bleeding and check brain size. If abnormalities are seen, MRI is usually done later.

19. Skeletal survey and bone age X-ray
A skeletal survey (multiple X-rays) can show overall bone growth, spine shape, and limb proportions. A hand and wrist X-ray can assess bone age. Advanced bone age or special bone patterns may support a diagnosis of an overgrowth syndrome.

20. Prenatal ultrasound and fetal imaging
In some pregnancies, fetal ultrasound may already show a big head, large body, or other anomalies. When prenatal overgrowth is detected, doctors may suggest targeted genetic testing for overgrowth syndromes, including deletions involving 17q11.2. Fetal MRI may also be used to study brain structure before birth..

Non-pharmacological treatments (therapies and others)

1. Genetic counseling and family education
Genetic counseling helps parents understand the cause of MMFD, how it was diagnosed, and what it might mean for future pregnancies. A counselor explains the chromosomal change, the chance of recurrence, and available reproductive options in simple language. This reduces guilt and confusion, supports informed choices, and encourages early developmental surveillance for other family members if needed. [7]

2. Early intervention developmental programs
Early intervention services (0–5 years) provide enriched play-based learning in homes or centers. Therapists work on communication, problem-solving, social skills, and self-care. For children with MMFD, starting these services as soon as delays are noticed can help build brain connections during a critical growth window and improve later school performance and independence. [8]

3. Physiotherapy for gross motor skills
Physiotherapists design exercises to improve balance, core strength, and coordination. Children with large heads and tall stature may be clumsy, fall easily, or have low muscle tone. Gentle strength training, balance games, and gait training help them sit, stand, and walk more safely, and reduce long-term joint strain and spinal problems such as scoliosis. [9]

4. Occupational therapy for fine motor and self-care
Occupational therapists focus on hand skills, dressing, feeding, writing, and sensory processing. In MMFD, motor planning and coordination can be affected along with cognition. Step-by-step training, adaptive tools (special cutlery, pencil grips), and sensory strategies (weighted vests, gentle pressure) support independence at home and school, lowering caregiver burden. [10]

5. Speech and language therapy
Speech-language pathologists assess understanding, expression, articulation, and sometimes swallowing. Many children with MMFD have language delay or social communication difficulties. Therapy uses play, pictures, and structured tasks to build vocabulary and sentence length. Alternative communication tools (picture boards, tablets) may be used to reduce frustration while speech develops. [11]

6. Behavioral and autism-focused interventions
Some MMFD patients show autistic traits or behavioral challenges such as hyperactivity, anxiety, or repetitive behaviors. Behavioral therapy and autism-specific programs (for example, structured teaching, social skills training, positive behavior support) help children learn routines, manage emotions, and interact better with peers, improving family functioning and school inclusion. [12]

7. Individualized education plans (IEP) and special education
Children with MMFD often need school accommodations. An individualized education plan can provide smaller class sizes, extra time, one-to-one support, and tailored teaching strategies. Regular review of the IEP helps match support to the child’s progress and prevents them from being left behind academically and socially. [13]

8. Vision assessment and low-vision support
Some overgrowth and NF1-related syndromes carry risk of optic pathway gliomas or other visual problems. Regular eye examinations detect reduced acuity, squint, or visual field loss early. If needed, glasses, patching, and visual rehabilitation strategies help the child maximize remaining vision and adapt school materials (large print, high-contrast text). [14]

9. Hearing evaluation and audiology support
Middle-ear fluid, nerve tumors, or cranial bone changes can affect hearing. Periodic hearing tests make sure speech and learning are not harmed by undetected hearing loss. Hearing aids, classroom FM systems, or cochlear implants in selected cases can dramatically improve language development and participation. [15]

10. Orthopedic and spine monitoring
Tall stature, abnormal bone growth, and spinal canal narrowing (foramen magnum stenosis, scoliosis) may occur. Regular orthopedic and spine reviews with X-rays or MRI when needed help detect dangerous compression of the spinal cord or nerves. Early use of braces, physiotherapy, or surgery can prevent permanent weakness or pain. [16]

11. Sleep assessment and management of sleep apnea
Children with macrocephaly and facial dysmorphism can develop obstructive sleep apnea due to upper-airway narrowing. Symptoms include snoring, pauses in breathing, and daytime sleepiness. Sleep studies (polysomnography) guide treatment such as weight management, nasal steroids, adenotonsillectomy, or CPAP/BiPAP. Better sleep improves mood, behavior, and growth. [17]

12. Nutritional counseling and healthy weight programs
Because macrosomia and overgrowth can progress into childhood obesity, dietitians help families plan balanced meals, manage portion sizes, and avoid excessive sugar and fat. A structured activity plan and screen-time limits reduce cardiometabolic risk and support bone and joint health, especially important in tall or rapidly growing children. [18]

13. Tumor surveillance and imaging follow-up
Where NF1 microdeletion is present, there is increased risk of plexiform neurofibromas and some malignant tumors. Regular clinical exams, appropriately timed MRI scans, and watching for red-flag symptoms (new pain, weakness, rapid growth of a lump) create an early-warning system so that tumors can be treated before causing severe complications. [19]

14. Neurosurgical monitoring for hydrocephalus and raised pressure
Macrocephaly sometimes hides important problems like hydrocephalus or foramen magnum stenosis. Neurosurgeons monitor imaging and neurological signs (vomiting, bulging fontanelle, weakness) and decide if a CSF shunt, endoscopic third ventriculostomy, or decompression surgery is needed to protect the brain and spinal cord. [20]

15. Psychological support for child and family
Living with a rare visible disorder is emotionally hard. Psychologists or counselors help children handle bullying, low self-esteem, and anxiety about tests or surgery. Parents can learn coping strategies, stress management, and ways to advocate for services, which protects both mental health and family relationships. [21]

16. Social work, care coordination, and community support
Social workers connect families to disability benefits, transport help, respite care, and parent support groups. They help coordinate between hospitals, schools, and local services so care plans are practical in real life. This reduces missed appointments, financial strain, and caregiver burnout. [22]

17. Dental and orthodontic care
Facial dysmorphism and macrocephaly can be associated with jaw misalignment, crowded teeth, or high-arched palate. Early dental and orthodontic assessment allows for preventive fluoride care, early extraction or braces planning, and advice on oral hygiene, reducing pain and infection and improving speech and appearance. [23]

18. Safety adaptation at home and school
Because children may be tall, top-heavy, or unsteady, the environment should be made safer: non-slip flooring, handrails, helmets when needed, and safe playground choices. Simple changes lower the risk of falls, head injury, and fractures, which are especially significant for children with spine or bone abnormalities. [24]

19. Reproductive and transition counseling in adolescence
As affected children grow into teenagers and adults, providers should discuss family-planning options, genetic testing in partners or embryos, and realistic expectations for independent living and work. A planned transition from pediatric to adult services prevents gaps in surveillance for tumors, cardiac issues, or orthopedic complications. [25]

20. Long-term follow-up in dedicated overgrowth or NF1 clinics
Whenever possible, care should be centralized in clinics that specialize in overgrowth or NF1-related disorders. Such teams are experienced with MMFD-like conditions and know current guidelines, clinical trials, and psychosocial resources. Centralized care improves early detection of complications and access to advanced treatments, including targeted therapies and surgery. [26]

---

Drug treatments

Important note: there is no single “cure” drug for MMFD. Medicines are used to treat complications such as plexiform neurofibromas, seizures, ADHD, or sleep problems. All dosing must be decided by a specialist; never start, change, or stop medicine without your doctor.

1. Selumetinib (KOSELUGO®)
Selumetinib is an oral MEK inhibitor approved by the FDA for children and now adults with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas. In MMFD patients who also have NF1 microdeletion and troublesome plexiform tumors, selumetinib can shrink tumor volume and ease pain or functional problems. Usual dosing is based on body surface area, taken twice daily, with common side effects including diarrhea, rash, and elevated liver enzymes. [1]

2. Mirdametinib (GOMEKLI™)
Mirdametinib is another oral MEK inhibitor recently approved for adults and children ≥2 years with NF1 and symptomatic plexiform neurofibromas that cannot be fully removed surgically. It is taken twice daily for 21 days followed by 7 days off in a 28-day cycle. In NF1-microdeletion patients with MMFD-like features, it offers an alternative targeted therapy to shrink plexiform tumors. Common side effects are skin rash, diarrhea, fatigue, and lab changes, so close monitoring is essential. [2]

3. Antiepileptic drugs (for seizures)
If MMFD is complicated by epilepsy, antiepileptic medicines such as levetiracetam, valproate, or lamotrigine may be used. These drugs stabilize electrical activity in the brain and reduce seizure frequency. Doses are carefully titrated according to weight, seizure type, and drug levels. Potential side effects include tiredness, mood changes, liver enzyme changes, and, for some drugs, effects on blood counts or skin. [3]

4. Baclofen or tizanidine (for spasticity)
When abnormal muscle tone or spasticity limits mobility, oral antispasticity agents such as baclofen or tizanidine may be prescribed. They act on spinal cord reflexes or central receptors to relax muscles and improve comfort, positioning, and function. Side effects include drowsiness, low blood pressure, and weakness, so careful adjustment and physiotherapy support are needed. [4]

5. Stimulant medications for ADHD-like symptoms
Some children with MMFD show inattention, impulsivity, or hyperactivity similar to ADHD. Stimulant medicines such as methylphenidate or amphetamine formulations can improve focus, school performance, and behavior when combined with behavioral strategies. Doses are started low and increased slowly. Common side effects are decreased appetite, difficulty sleeping, and sometimes increased heart rate or mood changes, which must be monitored closely. [5]

6. Non-stimulant ADHD medicines
When stimulants are not tolerated or contraindicated, non-stimulant agents such as atomoxetine or extended-release guanfacine may be used. These act on noradrenaline or alpha-2 receptors to reduce impulsivity and improve attention. They are usually taken once or twice daily. Possible side effects include tummy upset, fatigue, or changes in blood pressure or heart rate, so regular follow-up is important. [6]

7. Melatonin or other sleep-support medicines
Sleep is often disturbed by pain, anxiety, or sleep apnea. Low-dose melatonin, a hormone that signals night-time, can help regulate sleep onset in children. It is usually given in the evening under medical supervision. For severe sleep disorders related to mood or neurological issues, other medications may be considered by specialists, always combined with strong sleep-hygiene measures. [7]

8. Analgesics for pain control
Children with plexiform neurofibromas, skeletal deformities, or post-surgical pain may require pain relief. Paracetamol (acetaminophen) and, when needed, short courses of NSAIDs like ibuprofen are often used first. In severe chronic pain related to tumors or skeletal issues, specialist pain services may consider stronger medicines or adjuvant drugs (for example, gabapentin) with great care to avoid dependence or organ toxicity. [8]

9. Antihypertensive drugs
Overgrowth and NF1-related syndromes can be associated with high blood pressure due to renal artery stenosis, pheochromocytoma, or essential hypertension. ACE inhibitors, beta-blockers, or calcium-channel blockers may be used to protect the heart, brain, and kidneys. Drug choice depends on age and cause; careful monitoring of blood pressure and kidney function is required. [9]

10. Proton-pump inhibitors or H2 blockers
Gastro-esophageal reflux, common in children with neurological impairment or structural abnormalities, can cause pain, poor weight gain, and aspiration. Medicines like omeprazole (PPI) or ranitidine-type H2 blockers (where approved) reduce stomach acid production, easing symptoms and protecting the esophagus. Long-term use must be reviewed regularly to avoid unnecessary side effects. [10]

11. Growth-modifying therapies in selected overgrowth syndromes
In some overgrowth conditions, endocrinologists may consider therapies that influence growth hormone or related pathways when growth is extreme and harmful, though this is rare and highly individualized. Decisions balance benefits (reduced joint stress, improved function) against potential effects on metabolism and tumor risk, and such treatment must only occur in specialist centers. [11]

12. Anti-spasticity injections (botulinum toxin)
For focal spasticity affecting a few muscles, botulinum toxin injections can relax those muscles for several months, making physiotherapy and orthotic use more effective. This is often used around joints to improve range of motion, standing, or walking. Side effects are usually local weakness and require repeat injections at intervals if beneficial. [12]

13. Bisphosphonates in severe bone fragility (selected cases)
If MMFD overlaps with bone fragility or severe osteopenia, pediatric metabolic bone specialists may consider bisphosphonates (such as pamidronate) to strengthen bones, reduce fractures, and relieve bone pain. These drugs inhibit bone resorption and are given intravenously at intervals, with monitoring of calcium levels and kidney function. [13]

14. Antidepressants and anxiolytics
Older children and adults may experience depression or anxiety related to chronic illness, visible differences, or repeated medical procedures. When psychological therapies alone are not enough, SSRIs or other antidepressants may be added by child and adolescent psychiatrists. Doses are started low and monitored for side effects such as gastrointestinal upset, sleep change, or mood swings. [14]

15. Anti-migraine therapies
Macrocephaly and structural brain changes can be associated with headaches and migraines. Acute treatments (simple analgesics, triptans in older children) and preventive medications (such as propranolol or topiramate) may be used based on age and comorbidities. Identifying triggers and supporting regular sleep and hydration further improve headache control. [15]

16. Anti-reflux and pro-motility medicines for feeding issues
Children with oromotor dysfunction or severe reflux may benefit from pro-kinetic medicines alongside acid suppression, under specialist guidance. These can speed stomach emptying and reduce vomiting, protecting nutrition and lung health. Any medication is combined with feeding therapy, positioning strategies, and, where needed, tube-feeding plans. [16]

17. Hormonal therapies for puberty or menstrual management
Endocrine evaluation is important in overgrowth syndromes. If puberty occurs too early or periods cause severe distress in a child with heavy care needs, hormonal treatments (such as GnRH analogues for precocious puberty or hormonal contraception for menstrual control) may be considered after careful discussion of benefits and risks. [17]

18. Antibiotic prophylaxis in selected high-risk situations
If MMFD is associated with immune compromise, spinal hardware, or recurring chest infections, doctors may sometimes use short courses of antibiotics around surgeries or certain procedures to prevent serious infections. This is always tailored to local guidelines and the child’s history to avoid resistance and unnecessary exposure. [18]

19. Vitamin D and calcium supplementation
Children with mobility limitations or poor sunlight exposure are at risk of low vitamin D and weaker bones. Standard-dose vitamin D and calcium supplements, guided by blood tests, support bone mineralization and work together with physiotherapy and weight-bearing to reduce fracture risk. [19]

20. Standard supportive medicines (laxatives, inhalers, etc.) as needed
Depending on the child’s specific problems, routine medicines such as osmotic laxatives for constipation, bronchodilators and inhaled steroids for asthma-like symptoms, or antiemetics after surgery may be used. These are not specific to MMFD but are important to maintain comfort, nutrition, and respiratory health. [20]

---

Dietary molecular supplements

Evidence for disease-specific supplements in MMFD is limited. Most support is general and should never replace prescribed treatment. Always discuss supplements with the medical team.

1. Vitamin D – Supports bone mineralization and immune function. It helps the body absorb calcium and maintain strong bones, which is important for tall or immobile children. Dose is usually based on age and blood levels; both deficiency and overdose can be harmful. [1]

2. Calcium – Works with vitamin D to keep bones strong and reduce fracture risk. Where dietary intake is low, a supplement may be suggested. Too much calcium can cause kidney stones, so supplementation is guided by diet and blood tests. [2]

3. Omega-3 fatty acids (DHA/EPA) – Omega-3 fats from fish oil support brain development and may modestly help attention and behavior in some children, although evidence is mixed. They also have anti-inflammatory effects. Dosing is based on weight and product concentration; main side effects are mild stomach upset or fishy after-taste. [3]

4. Multivitamin with trace elements – A balanced multivitamin can fill small nutritional gaps in picky eaters or those with restricted diets. It provides B vitamins, zinc, and other micronutrients essential for growth, immune function, and wound healing. It should not exceed recommended daily allowances to avoid toxicity. [4]

5. Iron (if deficient) – Some children with chronic illness or restricted diets develop iron-deficiency anemia, causing fatigue and poor concentration. Oral iron supplements rebuild iron stores and hemoglobin. Dose is calculated by weight; common side effects are constipation and tummy discomfort, so stool-softening strategies may be needed. [5]

6. Folate and vitamin B12 (if low) – Folate and B12 are vital for red blood cell production and nervous system function. If blood tests show deficiency, supplementation can correct anemia and support neurological health. High-dose supplementation without proven deficiency is not recommended. [6]

7. Probiotics – In children with frequent antibiotics, reflux medicines, or feeding difficulties, selected probiotic strains may support gut microbiota and reduce antibiotic-associated diarrhea. Evidence varies by product and condition, so choice and duration should be discussed with clinicians. [7]

8. Protein-rich oral nutrition supplements – When calorie and protein needs are high due to growth, surgery, or chronic illness, specialized drinks or powders can help meet requirements. They provide concentrated protein, calories, vitamins, and minerals, and are usually used under dietitian supervision to avoid excess weight gain. [8]

9. Fiber supplements – For children with low fiber intake and chronic constipation, soluble fiber supplements can soften stool and support gut health when combined with adequate fluids. They must be introduced gradually to prevent bloating and should not substitute for fiber-rich foods. [9]

10. Antioxidant-rich diet pattern rather than high-dose pills – Fruits, vegetables, nuts, and whole grains provide natural antioxidants that support general health and may help protect tissues from oxidative stress. High-dose single antioxidant pills (for example, very high vitamin E) are usually avoided unless specifically indicated, because they can have adverse effects. [10]

---

Immune-support and regenerative / stem-cell related drugs

At present there are no standard stem-cell or regenerative drugs specifically proven for MMFD. Some general principles:

1. Routine childhood vaccines – The most important “immune-support” intervention is keeping vaccines up to date (including influenza and COVID-19 where recommended). Vaccines train the immune system to recognize and fight infections, protecting vulnerable children from serious disease. [1]

2. Immunoglobulin therapy (very selected cases) – If MMFD overlaps with a documented antibody deficiency, intravenous or subcutaneous immunoglobulin may be used to prevent recurrent severe infections. It provides pooled antibodies from donors and is given at regular intervals with monitoring for infusion reactions. [2]

3. Hematopoietic stem-cell transplantation (HSCT) – only for specific associated conditions
   HSCT is not a standard treatment for MMFD itself. In very rare situations where MMFD co-exists with another serious hematologic or immune disorder that is transplant-amenable, HSCT may be considered. It replaces the blood-forming system with donor stem cells, but carries major risks and is reserved for life-threatening disease. [3]

4. Targeted anti-tumor biologics (research and NF1 context)
   For complex NF1-related tumors, biologic drugs and targeted small molecules (like MEK inhibitors already mentioned) act on signaling pathways rather than the immune system directly. They are not regenerative drugs but can shrink tumors and preserve function, indirectly protecting organs and nerves. [4]

5. Erythropoiesis-stimulating agents in co-existing chronic anemia (selected)
   If a child has chronic kidney disease or other indications, erythropoiesis-stimulating agents may be used to boost red blood cell production. These are not MMFD-specific and carry risks such as hypertension and thrombosis, so use is very restricted and specialist-led. [5]

6. Experimental cell-based therapies (research only)
   Some overgrowth and genetic tumor-predisposition syndromes are being studied in early-phase trials using gene-based or cell-based treatments. These approaches remain experimental, involve small numbers of patients, and are only available in clinical trials with strict oversight. Families should discuss any trial offers carefully with trusted specialists. [6]

---

Surgeries and procedures (why they are done)

1. CSF shunt or endoscopic third ventriculostomy
   If hydrocephalus from blocked CSF flow causes macrocephaly, vomiting, or visual problems, neurosurgeons may place a shunt to divert fluid or perform an endoscopic third ventriculostomy to open a new drainage pathway. The goal is to relieve pressure on the brain, prevent further damage, and control head growth. [1]

2. Foramen magnum or spinal decompression
   In some MMFD-related conditions, the skull base is narrow and compresses the upper spinal cord. Decompression surgery removes bone or enlarges the opening to relieve pressure, improve breathing and swallowing, and prevent paralysis. It is usually considered when imaging and symptoms show progressive compression. [2]

3. Resection or debulking of plexiform neurofibromas
   When plexiform neurofibromas (in NF1 microdeletion) cause pain, deformity, airway compromise, or risk of malignant change, surgeons may remove or debulk them. Complete removal is often impossible without major nerve damage, so surgery is carefully weighed against targeted drug therapy like MEK inhibitors. [3]

4. Orthopedic surgery for deformities
   Severe scoliosis, limb length differences, or joint deformities may require orthopedic surgery such as spinal fusion, osteotomy, or guided growth procedures. These operations aim to improve alignment, reduce pain, and protect lung and heart function by keeping the chest and spine as normal as possible. [4]

5. Adenotonsillectomy or airway surgery
   If obstructive sleep apnea from enlarged tonsils/adenoids or airway narrowing is significant, ENT surgeons may remove tonsils and adenoids or perform other airway procedures. This can improve breathing, sleep quality, heart strain, and daytime behavior, and may reduce the need for CPAP in some children. [5]

---

Prevention and risk-reduction strategies

1. Early diagnosis and genetic confirmation – Prompt recognition of overgrowth, macrocephaly, and facial features allows early referral to genetics and specialized clinics, so complications can be anticipated and monitored rather than discovered late. [1]

2. Scheduled surveillance for tumors and orthopedic issues – Regular clinical exams, imaging when indicated, and spine checks can detect plexiform neurofibromas, scoliosis, or spinal stenosis before severe disability occurs, allowing earlier treatment. [2]

3. Healthy weight and activity – Preventing obesity with balanced diet and exercise reduces strain on joints and spine, lowers sleep apnea risk, and helps cardiovascular health in overgrown children. [3]

4. Infection prevention – Up-to-date vaccines, hand-hygiene routines, and quick treatment of respiratory infections help protect children with structural lung or airway issues from serious complications. [4]

5. Safe home and school environments – Adapting spaces with handrails, non-slip mats, and carefully chosen playground equipment reduces the risk of falls and head injuries in tall, top-heavy, or unsteady children. [5]

6. Regular developmental and learning assessments – Routine screening for speech, motor, and cognitive delay ensures early referral to therapies and educational support, preventing avoidable gaps in learning. [6]

7. Eye and hearing screening – Periodic checks can prevent long-term visual or hearing impairment from going unnoticed, especially when optic pathway tumors or ear problems may be present. [7]

8. Sun protection and skin checks – For NF1-related skin lesions, good sun protection and regular skin examinations can support early detection of suspicious changes, although evidence is extrapolated from general skin-cancer advice. [8]

9. Psychological resilience-building – Teaching coping skills, providing peer support, and addressing bullying early help prevent long-term mental-health problems in children with visible differences. [9]

10. Planned transition to adult care – Having a written transition plan from pediatric to adult services avoids loss to follow-up and ensures continued surveillance for tumors, heart issues, and orthopedic problems into adulthood. [10]

---

When to see doctors

Families should seek medical attention urgently if a child with MMFD develops red-flag symptoms such as rapid head growth, persistent vomiting, severe headache, new weakness, sudden visual changes, seizures, or breathing pauses during sleep. These signs can indicate raised intracranial pressure, hydrocephalus, spinal cord compression, or serious tumor growth, all of which need prompt assessment. [1]

Routine follow-up with the multidisciplinary team should be maintained at least yearly, and more often in early childhood or when new concerns appear. Parents should also contact their doctors if school regression, marked behavior changes, unexplained pain, or rapid change in size or texture of a neurofibroma occur, as these may signal complications that benefit from early investigation and treatment. [2]

---

What to eat and what to avoid”

1. Eat: varied fruits and vegetables every day for vitamins, minerals, and fiber. Avoid: very high-sugar snacks and drinks that add calories without nutrients and worsen obesity risk. [1]

2. Eat: whole grains (brown rice, whole-wheat bread, oats) to support steady energy and bowel health. Avoid: relying mainly on refined grains like white bread and pastries, which cause rapid blood-sugar spikes. [2]

3. Eat: lean proteins such as fish, poultry, beans, lentils, and eggs to support growth, muscle strength, and tissue repair after surgeries. Avoid: frequent processed meats high in salt and preservatives. [3]

4. Eat: healthy fats from nuts, seeds, olive oil, and oily fish, which provide essential fatty acids for brain and heart health. Avoid: large amounts of trans fats and deep-fried foods that promote weight gain and cardiovascular risk. [4]

5. Eat: dairy or fortified alternatives for calcium and vitamin D, unless contraindicated. Avoid: excessive sugary flavored milks or energy drinks that add unnecessary sugar and caffeine. [5]

6. Eat: adequate fiber through fruits, vegetables, whole grains, and legumes to help prevent constipation, especially in less mobile children. Avoid: very low-fiber “white” diets that worsen bowel problems. [6]

7. Eat: small, regular meals and snacks if the child tires easily at mealtimes, using high-nutrient foods like yogurt, nuts (if age-safe), or hummus. Avoid: grazing all day on low-nutrient snacks, which can displace proper meals and disturb appetite cues. [7]

8. Drink: plenty of water throughout the day to support kidney function and gut health. Avoid: frequent sugary sodas, sports drinks, and high-caffeine beverages, which contribute to weight gain and may worsen sleep problems. [8]

9. Eat: when appropriate, oily fish one to two times per week to provide natural omega-3 fatty acids for brain and heart health. Avoid: large amounts of fish known to be high in mercury in young children or pregnancy. [9]

10. Follow: any specific texture or allergy advice from speech therapists or allergists (for example, thickened fluids, soft foods). Avoid: foods that increase choking risk or violate medical guidance, especially if swallowing is impaired. [10]

---

Frequently asked questions (FAQs)

1. Is macrocephaly, macrosomia, and facial dysmorphism syndrome curable?
No. MMFD is a genetic condition caused by changes in chromosome 17q11.2, particularly the RNF135 region and sometimes NF1. Current treatments cannot remove this genetic change, but many complications can be managed effectively with supportive care, surgery, and, for NF1-related tumors, targeted drug therapy. [1]

2. Will my child’s head keep growing forever?
Head growth is usually most rapid in the first few years and then slows. Children with MMFD may stay on a higher head-size curve than peers but do not usually show unlimited head growth. Regular measurement and imaging help distinguish benign large head from hydrocephalus or other treatable problems. [2]

3. Does MMFD always include neurofibromatosis type 1?
Not always. Some patients have deletions that include both RNF135 and NF1, leading to overlapping MMFD and NF1 features; others have RNF135 changes without classic NF1 manifestations. Genetic testing clarifies exactly which genes are affected and guides tumor surveillance and treatment decisions. [3]

4. Can MMFD be seen on prenatal ultrasound?
Sometimes. Features like increased head size, overall overgrowth, or certain structural anomalies may be visible on detailed ultrasound or fetal MRI. However, many findings are subtle, and a definite diagnosis usually requires postnatal examination and molecular genetic testing. [4]

5. What is the long-term outlook for children with MMFD?
Outcomes vary. Many children have lifelong learning difficulties but can achieve good quality of life with appropriate support. Prognosis depends on the severity of neurological involvement, presence of tumors (especially plexiform neurofibromas), and complications like hydrocephalus or spinal cord compression, which are treatable if detected early. [5]

6. Will my next baby also have MMFD?
Recurrence risk depends on whether the chromosomal change arose de novo or was inherited. If one parent carries the rearrangement, the chance can be as high as 50%. If both parents have normal chromosomes on testing, the risk is usually much lower but not zero. A genetic counselor can provide individualized figures and options such as prenatal or preimplantation testing. [6]

7. Are there lifestyle changes that can “fix” the syndrome?
Lifestyle changes cannot alter the underlying genetic cause. However, healthy diet, physical activity, sleep routines, and strong developmental and educational support can greatly improve overall health, learning, and emotional wellbeing, reducing the impact of the condition on daily life. [7]

8. Do all children with MMFD need brain surgery?
No. Surgery is only needed if imaging and symptoms show serious problems such as hydrocephalus, foramen magnum stenosis, or large symptomatic tumors. Many children are managed with observation and non-surgical therapies alone. Decisions are made by neurosurgeons after careful assessment of risks and benefits. [8]

9. Are MEK inhibitors like selumetinib or mirdametinib right for every child with MMFD?
These drugs are specifically approved for patients with NF1 and symptomatic, inoperable plexiform neurofibromas. Children with MMFD but without NF1-type tumors do not benefit from MEK inhibitors. Even in eligible patients, treatment is complex and requires a specialist team experienced in these medicines and their side effects. [9]

10. Can MMFD cause cancer?
Chromosome 17q11.2 deletions that include NF1 increase the risk of certain tumors, including plexiform neurofibromas, optic pathway gliomas, and malignant peripheral nerve sheath tumors. The absolute risk for an individual child varies. Regular follow-up and early investigation of new pain, neurologic changes, or rapidly growing masses are essential. [10]

11. Will my child always look very different from others?
Facial features often become less obvious with time, although height and head size may remain above average. Supportive therapies, orthodontic care, and, in some cases, surgery can improve function and appearance. Just as important is emotional support to build confidence and resilience in social situations. [11]

12. Can special schooling help?
Yes. Tailored education plans, specialist teaching strategies, and therapies in school settings are key to helping children reach their potential. Many benefit from a mix of mainstream and special education services, depending on their strengths and difficulties. [12]

13. Is exercise safe for children with MMFD?
In general, regular physical activity is encouraged, but the type and intensity should be adjusted based on spine stability, joint health, and any heart or lung issues. Physiotherapists can design safe programs. Contact sports may be restricted if there are spinal, vascular, or tumor-related risks. [13]

14. How often should my child have imaging studies?
There is no single schedule for everyone. Imaging frequency depends on symptoms, specific gene changes, and previous findings. Some children need periodic brain and spine MRI or targeted imaging for known tumors; others may only need imaging if new symptoms arise. Your specialist clinic sets an individualized plan. [14]

15. Where can families find more support?
Families can seek help from national or regional rare disease networks, NF1 foundations when NF1 is involved, and local parent support groups. These organizations provide education materials, advocacy, and emotional support and often share information about clinical trials and specialist centers. [15]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: January 16, 2026.